12th Nov 2015 10:04
LONDON (Alliance News) - Premaitha Health PLC on Thursday noted a positive independent study on the use of its IONA non-invasive pre-natal screening test.
The study, published in the Journal of Ultrasound, Obstetrics in Gynecology, showed robust detection rates across trisomy and a 0% false positive rate under the tested conditions.
"We at Premaitha are delighted with the results of the study and are grateful to be working with our collaborators as we strive to improve prenatal care for all expectant parents and those caring for them," said William Denman, Premaitha's chief medical officer.
Shares in Premaitha were up 3.4% to 18.10 pence on Thursday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health